Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 15 | 2025 | 237 | 1.580 |
Why?
|
| Palatine Tonsil | 8 | 2010 | 34 | 0.970 |
Why?
|
| Adenoids | 6 | 2010 | 12 | 0.840 |
Why?
|
| Hypoxia | 8 | 2012 | 244 | 0.800 |
Why?
|
| Polysomnography | 9 | 2025 | 156 | 0.690 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2012 | 94 | 0.470 |
Why?
|
| Adenoidectomy | 5 | 2011 | 84 | 0.380 |
Why?
|
| Snoring | 5 | 2017 | 18 | 0.370 |
Why?
|
| Tonsillectomy | 5 | 2011 | 111 | 0.360 |
Why?
|
| Erythropoietin | 1 | 2012 | 104 | 0.350 |
Why?
|
| Cognition Disorders | 3 | 2012 | 557 | 0.350 |
Why?
|
| Leukotriene Antagonists | 1 | 2008 | 16 | 0.290 |
Why?
|
| Vasculitis | 1 | 2007 | 46 | 0.260 |
Why?
|
| Posture | 1 | 2007 | 120 | 0.250 |
Why?
|
| Disease Models, Animal | 5 | 2012 | 4664 | 0.240 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2025 | 123 | 0.220 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 466 | 0.220 |
Why?
|
| Maze Learning | 4 | 2012 | 97 | 0.200 |
Why?
|
| NADPH Oxidases | 3 | 2012 | 108 | 0.190 |
Why?
|
| Narcolepsy | 1 | 2022 | 8 | 0.190 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2022 | 44 | 0.180 |
Why?
|
| Child, Preschool | 15 | 2025 | 14987 | 0.170 |
Why?
|
| Obesity | 3 | 2011 | 2389 | 0.170 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2022 | 190 | 0.170 |
Why?
|
| Embryonic Stem Cells | 2 | 2011 | 158 | 0.160 |
Why?
|
| Child | 19 | 2025 | 26145 | 0.160 |
Why?
|
| Bone Marrow Cells | 2 | 2011 | 241 | 0.150 |
Why?
|
| Gene Regulatory Networks | 3 | 2011 | 380 | 0.150 |
Why?
|
| Hypertrophy | 5 | 2010 | 102 | 0.140 |
Why?
|
| Cells, Cultured | 4 | 2012 | 2903 | 0.140 |
Why?
|
| Tick Paralysis | 1 | 2017 | 1 | 0.140 |
Why?
|
| Tick-Borne Diseases | 1 | 2017 | 16 | 0.130 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 498 | 0.130 |
Why?
|
| Lipid Peroxidation | 3 | 2012 | 91 | 0.130 |
Why?
|
| Severity of Illness Index | 6 | 2017 | 3053 | 0.130 |
Why?
|
| DiGeorge Syndrome | 1 | 2017 | 80 | 0.130 |
Why?
|
| Muscle Weakness | 1 | 2017 | 88 | 0.130 |
Why?
|
| Oximetry | 1 | 2017 | 178 | 0.120 |
Why?
|
| Sleep | 3 | 2022 | 373 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2022 | 700 | 0.120 |
Why?
|
| Male | 24 | 2022 | 64557 | 0.120 |
Why?
|
| Epilepsy | 2 | 2017 | 879 | 0.120 |
Why?
|
| Deoxyguanosine | 2 | 2012 | 12 | 0.120 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 2343 | 0.120 |
Why?
|
| Swimming | 2 | 2012 | 28 | 0.110 |
Why?
|
| Analysis of Variance | 3 | 2012 | 944 | 0.110 |
Why?
|
| Cell Proliferation | 4 | 2009 | 2468 | 0.110 |
Why?
|
| Case-Control Studies | 4 | 2010 | 3413 | 0.110 |
Why?
|
| Cell Culture Techniques | 3 | 2009 | 276 | 0.100 |
Why?
|
| Tonsillitis | 2 | 2010 | 13 | 0.100 |
Why?
|
| Women | 1 | 2012 | 17 | 0.090 |
Why?
|
| Injections, Intraperitoneal | 1 | 2012 | 66 | 0.090 |
Why?
|
| Female | 19 | 2025 | 70509 | 0.090 |
Why?
|
| Malondialdehyde | 1 | 2012 | 49 | 0.090 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 23 | 0.090 |
Why?
|
| Escape Reaction | 1 | 2012 | 21 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 5 | 2012 | 4701 | 0.090 |
Why?
|
| Humans | 23 | 2025 | 130574 | 0.090 |
Why?
|
| Cell Shape | 1 | 2011 | 68 | 0.090 |
Why?
|
| Evoked Potentials | 2 | 2009 | 119 | 0.080 |
Why?
|
| Actigraphy | 1 | 2011 | 53 | 0.080 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 78 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 413 | 0.080 |
Why?
|
| Bronchiolitis, Viral | 1 | 2009 | 29 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 315 | 0.080 |
Why?
|
| Time Factors | 4 | 2012 | 6223 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2011 | 1843 | 0.070 |
Why?
|
| Adaptation, Psychological | 1 | 2012 | 431 | 0.070 |
Why?
|
| SRS-A | 1 | 2008 | 1 | 0.070 |
Why?
|
| Leukotriene D4 | 1 | 2008 | 5 | 0.070 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2010 | 110 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 449 | 0.070 |
Why?
|
| Cytokines | 3 | 2009 | 1341 | 0.070 |
Why?
|
| Memory | 1 | 2012 | 353 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 411 | 0.070 |
Why?
|
| Sulfides | 1 | 2008 | 22 | 0.070 |
Why?
|
| Androstadienes | 1 | 2008 | 50 | 0.070 |
Why?
|
| Cyclopropanes | 1 | 2008 | 72 | 0.070 |
Why?
|
| RNA Polymerase II | 1 | 2008 | 89 | 0.070 |
Why?
|
| Acetates | 1 | 2008 | 79 | 0.070 |
Why?
|
| Catechin | 1 | 2008 | 12 | 0.070 |
Why?
|
| Hydroxyurea | 1 | 2008 | 85 | 0.070 |
Why?
|
| Apoptosis | 3 | 2010 | 1849 | 0.070 |
Why?
|
| Interleukins | 1 | 2008 | 122 | 0.070 |
Why?
|
| Quinolines | 1 | 2008 | 118 | 0.070 |
Why?
|
| Hyperemia | 1 | 2007 | 31 | 0.070 |
Why?
|
| CD40 Ligand | 1 | 2007 | 65 | 0.070 |
Why?
|
| Middle Ear Ventilation | 1 | 2007 | 37 | 0.070 |
Why?
|
| Tyrosine | 1 | 2007 | 138 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2012 | 553 | 0.070 |
Why?
|
| Otolaryngology | 1 | 2009 | 114 | 0.070 |
Why?
|
| Attention | 1 | 2009 | 192 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2008 | 252 | 0.060 |
Why?
|
| Otitis Media | 1 | 2007 | 89 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 564 | 0.060 |
Why?
|
| Prefrontal Cortex | 1 | 2008 | 214 | 0.060 |
Why?
|
| Plant Extracts | 1 | 2008 | 136 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2008 | 341 | 0.060 |
Why?
|
| Hippocampus | 2 | 2008 | 802 | 0.060 |
Why?
|
| Adolescent | 5 | 2017 | 20774 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 301 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2009 | 1684 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 240 | 0.060 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2009 | 385 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1592 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2009 | 559 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2556 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1622 | 0.060 |
Why?
|
| Arginine | 1 | 2007 | 335 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2007 | 467 | 0.050 |
Why?
|
| Sleep Wake Disorders | 1 | 2007 | 205 | 0.050 |
Why?
|
| Infant | 3 | 2009 | 13306 | 0.050 |
Why?
|
| Mice | 5 | 2012 | 18224 | 0.050 |
Why?
|
| Body Weight | 1 | 2007 | 988 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2009 | 783 | 0.050 |
Why?
|
| Animals | 7 | 2012 | 33899 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2009 | 5085 | 0.050 |
Why?
|
| Asthma | 1 | 2011 | 921 | 0.050 |
Why?
|
| Risk Factors | 4 | 2009 | 10993 | 0.050 |
Why?
|
| Cognition | 1 | 2008 | 816 | 0.050 |
Why?
|
| Age Factors | 1 | 2009 | 2844 | 0.050 |
Why?
|
| Neurons | 1 | 2012 | 2007 | 0.050 |
Why?
|
| Inflammation | 1 | 2009 | 1489 | 0.040 |
Why?
|
| Chemokines | 2 | 2011 | 124 | 0.040 |
Why?
|
| Lung | 1 | 2008 | 1575 | 0.040 |
Why?
|
| Comorbidity | 3 | 2011 | 1595 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 2646 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 6475 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2010 | 226 | 0.040 |
Why?
|
| Rats | 3 | 2008 | 3412 | 0.030 |
Why?
|
| Kentucky | 2 | 2007 | 28 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2010 | 772 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2017 | 44 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 783 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 1033 | 0.030 |
Why?
|
| Electromyography | 1 | 2017 | 138 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 3844 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2008 | 1136 | 0.030 |
Why?
|
| Incidence | 1 | 2022 | 3344 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2009 | 958 | 0.030 |
Why?
|
| Recurrence | 2 | 2009 | 1479 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 4034 | 0.030 |
Why?
|
| Electroencephalography | 2 | 2009 | 858 | 0.020 |
Why?
|
| NADPH Oxidase 2 | 1 | 2011 | 37 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2010 | 27 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2932 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2010 | 35 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2010 | 34 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 1680 | 0.020 |
Why?
|
| Wakefulness | 1 | 2011 | 103 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 153 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 61 | 0.020 |
Why?
|
| Phenotype | 2 | 2011 | 4479 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 135 | 0.020 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2008 | 2 | 0.020 |
Why?
|
| Self Report | 1 | 2012 | 557 | 0.020 |
Why?
|
| Fluticasone | 1 | 2008 | 16 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2008 | 23 | 0.020 |
Why?
|
| Cullin Proteins | 1 | 2008 | 13 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2022 | 17653 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2008 | 34 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 213 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2007 | 3816 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 31202 | 0.020 |
Why?
|
| Tea | 1 | 2008 | 18 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 1006 | 0.020 |
Why?
|
| Serine | 1 | 2008 | 161 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 427 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 426 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2007 | 31 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 868 | 0.020 |
Why?
|
| Causality | 1 | 2007 | 91 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 2007 | 71 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2007 | 109 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 510 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 587 | 0.020 |
Why?
|
| RNA | 1 | 2010 | 517 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 544 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 680 | 0.010 |
Why?
|
| Computational Biology | 1 | 2011 | 868 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 832 | 0.010 |
Why?
|
| Brain | 1 | 2017 | 3189 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2008 | 432 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 2609 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 2201 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 2683 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2008 | 1017 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 3835 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2008 | 804 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1601 | 0.010 |
Why?
|
| Parents | 1 | 2009 | 1108 | 0.010 |
Why?
|
| Quality of Life | 1 | 2011 | 2087 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 3397 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 1694 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 12891 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 20925 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 28448 | 0.010 |
Why?
|